StockWatch
·
HomeLiveWeekly

Fulcrum Therapeutics, Inc.

Ticker: 1680581

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-40.504.9150.3195.72Q3 FY2022Q1 FY2023Q1 FY2023Q2 FY2023Q3 FY2023Q3 FY2023Q2 FY2024Q2 FY2024

Margin Trend

percentage
OPM %NPM %
-125.39-52.0421.3094.65Q3 FY2022Q1 FY2023Q1 FY2023Q2 FY2023Q3 FY2023Q3 FY2023Q2 FY2024Q2 FY2024
PeriodQ2 FY2024Q2 FY2024Q3 FY2023Q3 FY2023Q2 FY2023Q1 FY2023Q1 FY2023Q3 FY2022
INCOME
Revenue80.00+0.0%80.00+10426.3%0.76+0.0%0.76-13.6%0.88+193.3%0.30+0.0%0.30-74.6%1.18
Total Income80.00+0.0%80.00+10426.3%0.76+0.0%0.76-13.6%0.88+193.3%0.30+0.0%0.30-74.6%1.18
EXPENSES
Expenditure27.51+0.0%27.51-2.4%28.20+0.0%28.20+0.1%28.17-0.2%28.24+0.0%28.24+10.6%25.54
PROFIT
Net Profit55.41+0.0%55.41+330.7%-24.02+0.0%-24.02-1.0%-23.78+4.0%-24.78+0.0%-24.78-4.4%-23.74
KEY METRICS
OPM %65.61%65.61%+165.61pp-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %69.26%69.26%+169.26pp-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS0.89+0.0%0.89+328.2%-0.39+0.0%-0.39-2.6%-0.38+7.3%-0.41+0.0%-0.41+19.6%-0.51

Corporate Events

Board MeetingFULC
2026
24Jun

Board Meeting

Annual Meeting of Stockholders to elect Class I directors, a…

SEC Filing ↗
Board MeetingFULC
2026
5Jun

Board Meeting

Retention payments and change-in-control benefits approved f…

SEC Filing ↗